Constructing Linear-Oriented Pre-Vascularized Human Spinal Cord Tissues for Spinal Cord Injury Repair
© 2024 Wiley‐VCH GmbH..
Repairing spinal cord injury (SCI) is a global medical challenge lacking effective clinical treatment. Developing human-engineered spinal cord tissues that can replenish lost cells and restore a regenerative microenvironment offers promising potential for SCI therapy. However, creating vascularized human spinal cord-like tissues (VSCT) that mimic the diverse cell types and longitudinal parallel structural features of spinal cord tissues remains a significant hurdle. In the present study, VSCTs are engineered using embryonic human spinal cord-derived neural and endothelial cells on linear-ordered collagen scaffolds (LOCS). Studies have shown that astrocytes and endothelial cells align along the scaffolds in VSCT, supporting axon extension from various human neurons myelinated by oligodendrocytes. After transplantation into SCI rats, VSCT survives at the injury sites and promotes endogenous neural regeneration and vascularization, ultimately reducing scarring and enhancing behavioral functional recovery. It suggests that pre-vascularization of engineered spinal cord tissues is beneficial for SCI treatment and highlights the important role of exogenous endothelial cells in tissue engineering.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Advanced healthcare materials - (2024) vom: 27. März, Seite e2303388 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Fan, Caixia [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Revised 04.04.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1002/adhm.202303388 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370266633 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM370266633 | ||
003 | DE-627 | ||
005 | 20240404235207.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240329s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/adhm.202303388 |2 doi | |
028 | 5 | 2 | |a pubmed24n1364.xml |
035 | |a (DE-627)NLM370266633 | ||
035 | |a (NLM)38537119 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Fan, Caixia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Constructing Linear-Oriented Pre-Vascularized Human Spinal Cord Tissues for Spinal Cord Injury Repair |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 04.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a © 2024 Wiley‐VCH GmbH. | ||
520 | |a Repairing spinal cord injury (SCI) is a global medical challenge lacking effective clinical treatment. Developing human-engineered spinal cord tissues that can replenish lost cells and restore a regenerative microenvironment offers promising potential for SCI therapy. However, creating vascularized human spinal cord-like tissues (VSCT) that mimic the diverse cell types and longitudinal parallel structural features of spinal cord tissues remains a significant hurdle. In the present study, VSCTs are engineered using embryonic human spinal cord-derived neural and endothelial cells on linear-ordered collagen scaffolds (LOCS). Studies have shown that astrocytes and endothelial cells align along the scaffolds in VSCT, supporting axon extension from various human neurons myelinated by oligodendrocytes. After transplantation into SCI rats, VSCT survives at the injury sites and promotes endogenous neural regeneration and vascularization, ultimately reducing scarring and enhancing behavioral functional recovery. It suggests that pre-vascularization of engineered spinal cord tissues is beneficial for SCI treatment and highlights the important role of exogenous endothelial cells in tissue engineering | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a neural regeneration | |
650 | 4 | |a spinal cord injury | |
650 | 4 | |a tissue engineering | |
650 | 4 | |a vascularization | |
700 | 1 | |a Cai, Hui |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Lulu |e verfasserin |4 aut | |
700 | 1 | |a Wu, Xianming |e verfasserin |4 aut | |
700 | 1 | |a Yan, Junyan |e verfasserin |4 aut | |
700 | 1 | |a Jin, Lifang |e verfasserin |4 aut | |
700 | 1 | |a Hu, Baowei |e verfasserin |4 aut | |
700 | 1 | |a He, Jiaxiong |e verfasserin |4 aut | |
700 | 1 | |a Chen, Yanyan |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Yannan |e verfasserin |4 aut | |
700 | 1 | |a Dai, Jianwu |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Advanced healthcare materials |d 2012 |g (2024) vom: 27. März, Seite e2303388 |w (DE-627)NLM218710070 |x 2192-2659 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:27 |g month:03 |g pages:e2303388 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/adhm.202303388 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 27 |c 03 |h e2303388 |